Adaptive Biotechnologies (ADPT) Other Gross PP&E Adjustments: 2018-2025
Historic Other Gross PP&E Adjustments for Adaptive Biotechnologies (ADPT) over the last 7 years, with Sep 2025 value amounting to -$42.0 million.
- Adaptive Biotechnologies' Other Gross PP&E Adjustments rose 9.76% to -$42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.6 million, marking a year-over-year increase of 32.50%. This contributed to the annual value of $87.7 million for FY2024, which is 3.91% up from last year.
- Adaptive Biotechnologies' Other Gross PP&E Adjustments amounted to -$42.0 million in Q3 2025, which was up 3.12% from -$43.3 million recorded in Q2 2025.
- In the past 5 years, Adaptive Biotechnologies' Other Gross PP&E Adjustments ranged from a high of $87.7 million in Q4 2024 and a low of -$92.9 million during Q2 2021.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$46.5 million (2024), whereas its average is -$30.4 million.
- As far as peak fluctuations go, Adaptive Biotechnologies' Other Gross PP&E Adjustments slumped by 177.65% in 2021, and later skyrocketed by 73.59% in 2022.
- Adaptive Biotechnologies' Other Gross PP&E Adjustments (Quarterly) stood at $30.1 million in 2021, then soared by 73.59% to $52.3 million in 2022, then soared by 61.49% to $84.4 million in 2023, then climbed by 3.91% to $87.7 million in 2024, then grew by 9.76% to -$42.0 million in 2025.
- Its last three reported values are -$42.0 million in Q3 2025, -$43.3 million for Q2 2025, and -$44.0 million during Q1 2025.